In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology published a consensus on primary ...

Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, resulting in chronic cholestasis, portal inflammation ...

The association between celiac disease and primary biliary cirrhosis is well established. The breakdown of gut–liver axis equilibrium plays a central role in the development of immune disorders ...

The global primary biliary cholangitis therapeutics market size was valued at US$732.5 million in 2023 and is projected to reach US$1358.1 billion by 2032, growing at a CAGR of 7.1% from 2024 to 2032.

Michelle Tratchenberg, 39, had received a liver transplant in the months leading up to her death. While a cause of death has ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

and alpha 1 antitrypsin deficiency non-alcoholic fatty liver disease primary biliary cirrhosis (PBC) Smoking increases your risk of many different cancers, including liver cancer. In the UK, 20 out of ...

Primary biliary cholangitis (PBC ... "PBC is one of those liver diseases where you can have cirrhosis and liver failure if you don't do anything about it in a matter of 10 to 15 years," said ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

or congenital biliary anomalies, is a common devastating liver dysfunction, resulting in liver toxicity, cirrhosis, and eventually hepatic failure. Therapy for obstructive cholestasis is mainly ...